Anika Therapeutics, Inc.: 10-Q filed 2014-11-06
What Anika Therapeutics, Inc. reported in its quarterly report filed 2014-11-06 (fiscal Q3 2014): 38 published measures, 103 facts as tagged in accession 0001171843-14-005281.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-11-06
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001171843-14-005281 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Anika Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 185,497,590 | USD | |
| At 2013-12-31 | 156,041,881 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 169,704,505 | USD | |
| At 2013-12-31 | 135,634,031 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 71,772,194 | USD | |
| At 2013-12-31 | 63,333,160 | USD | |
| At 2013-09-30 | 64,055,438 | USD | |
| At 2012-12-31 | 44,067,477 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 6,170,800 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 30,503,403 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 4,957,258 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 13,920,152 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 25,222,372 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 17,159,199 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 920,132 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 235,803 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 4,267,102 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 2,496,830 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -20,919,301 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 295,062 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 97,087,605 | USD | |
| At 2013-12-31 | 66,584,202 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 14,758,781 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 14,626,933 | shares | 273 |
| 2013-07-01 to 2013-09-30 | 13,682,449 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 13,534,334 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 15,434,875 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 15,469,237 | shares | 273 |
| 2013-07-01 to 2013-09-30 | 14,958,965 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 14,673,879 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 0.42 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 2.09 | USD/shares | 273 |
| 2013-07-01 to 2013-09-30 | 0.36 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | 1.03 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 0.4 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 1.97 | USD/shares | 273 |
| 2013-07-01 to 2013-09-30 | 0.33 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | 0.95 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 4,125,355 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 18,872,435 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 2,776,199 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 8,147,282 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 32,036,643 | USD | |
| At 2013-12-31 | 32,938,711 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 1,196,361 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 1,156,929 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 10,286,218 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 49,359,499 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 7,766,273 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 22,176,189 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 128,655,654 | USD | |
| At 2013-12-31 | 94,591,787 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 6,434,123 | USD | |
| At 2013-12-31 | 9,282,501 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,167,545 | USD | |
| At 2013-12-31 | 2,793,911 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 8,702,295 | USD | |
| At 2014-06-30 | 9,360,884 | USD | |
| At 2013-12-31 | 9,443,894 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 20,170,095 | USD | |
| At 2013-12-31 | 18,736,845 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 13,582,456 | USD | |
| At 2013-12-31 | 10,996,785 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 4,044,538 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 11,401,399 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 3,188,669 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 10,536,462 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 1,999,867 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 6,160,740 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,618,012 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,029,974 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 14,800,453 | shares | |
| At 2013-12-31 | 14,289,308 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 53,379,965 | USD | |
| At 2013-12-31 | 52,413,423 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 21,343,322 | USD | |
| At 2013-12-31 | 19,474,712 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 16,033,944 | USD | |
| At 2013-12-31 | 18,998,409 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 948,858 | USD | |
| At 2013-12-31 | 1,133,544 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 5,253,693 | USD | |
| At 2013-12-31 | 5,537,881 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,128,693 | USD | |
| At 2013-12-31 | 865,957 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 10,296,155 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 49,375,838 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 7,733,457 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 22,067,434 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 4,491,263 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 28,607,011 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 5,873,732 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 14,427,271 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 518,699 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,593,260 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 521,387 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,555,796 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 1,840,407 | USD | 273 |
| 2013-01-01 to 2013-09-30 | -4,667,839 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 2,923,628 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 3,430,655 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -992,822 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 124,679 | USD | 273 |
Inspect the source
- Entity
- Anika Therapeutics, Inc. / CIK 0000898437
- Captured
- 2026-09-20T05:04:56.960Z
- SEC response SHA-256
f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))